Abbott today announced the launch of its neuromodulation business’ next-generation delivery system, which will be used to streamline the implantation process for electrodes used as part of its ...
Abbott (NYSE: ABT) announced today that it launched a next-generation delivery system for its neuromodulation business.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback